ONIMBRI Trademark

Trademark Overview

On Friday, October 23, 2020, a trademark application was filed for ONIMBRI with the United States Patent and Trademark Office. The USPTO has given the ONIMBRI trademark a serial number of 90273851. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2024. This trademark is owned by AbbVie Inc.. The ONIMBRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
onimbri

General Information

Serial Number90273851
Word MarkONIMBRI
Filing DateFriday, October 23, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Tuesday, October 27, 2020NEW APPLICATION ENTERED
Friday, December 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 24, 2021ASSIGNED TO EXAMINER
Friday, March 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 22, 2021SOU TEAS EXTENSION RECEIVED
Monday, November 22, 2021SOU EXTENSION 1 FILED
Monday, November 22, 2021SOU EXTENSION 1 GRANTED
Wednesday, November 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 27, 2022SOU EXTENSION 2 FILED
Monday, June 27, 2022SOU EXTENSION 2 GRANTED
Wednesday, December 14, 2022SOU EXTENSION 3 GRANTED
Wednesday, June 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022SOU EXTENSION 3 FILED
Friday, December 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 27, 2023SOU EXTENSION 4 FILED
Tuesday, June 27, 2023SOU EXTENSION 4 GRANTED
Thursday, June 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 29, 2023SOU EXTENSION 5 FILED
Friday, January 5, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, January 5, 2024PETITION TO REVIVE-GRANTED
Friday, January 5, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, January 5, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, February 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 21, 2024SOU EXTENSION 5 GRANTED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 5, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

onimbri gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related